These critical questions emphasize the need for a systematic analysis of the requirements for protection by NA and HA independently, and together, to determine if the theoretical upper limit for NA in a virion is enough to overcome the NA quantity bottleneck in current influenza vaccines that are dosed based on HA amounts. This evidence concerns the gene XK and influenza.